Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Aug 28, 2026

BOLT — Bolt Biotherapeutics, Inc. Dilution Risk Tracker

Track BOLT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BOLT — Get alerts when the score changes →

As of August 28, 2026, Bolt Biotherapeutics, Inc. (BOLT) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Bolt Biotherapeutics, Inc. has a market capitalization of $10.09M, 1.93M shares outstanding, 24 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
🔔 Track BOLT — Get forecast alerts →

Market Data

Market Cap$10.09M
Shares Outstanding1.93M
Float1.77M
Cash$17.60M
Debt$22.31M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)
24 institutional holders · 699.0K shares
#1 Vivo Capital, LLC 144.8K shares
#2 Sofinnova Investments, Inc. 137.7K shares
#3 RENAISSANCE TECHNOLOGIES LLC 77.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.7K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-02-04
4 INSIDER TRANSACTION 2026-02-04
4 INSIDER TRANSACTION 2026-02-04
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BOLT Dilution Snapshot

Bolt Biotherapeutics, Inc. (BOLT) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BOLT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BOLT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BOLT
BOLT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.